Cost-effectiveness of Cervical Cancer Prevention

Cost-effectiveness analyses are an important tool for the evaluation and modification of many health care services. Given the variety of screening tests and treatments available for cervical cancer screening and prevention, the costs associated with these options and with their alternatives, and the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical obstetrics and gynecology 2013-03, Vol.56 (1), p.55-64
Hauptverfasser:	M. ESSELEN, KATHARINE, FELDMAN, SARAH
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost-Benefit Analysis Developing Countries - economics Early Detection of Cancer - economics Female Human Papillomavirus DNA Tests - economics Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Markov Chains Papillomavirus Infections - diagnosis Papillomavirus Vaccines - economics Quality-Adjusted Life Years United States Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - prevention & control Vaginal Smears - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cost-effectiveness analyses are an important tool for the evaluation and modification of many health care services. Given the variety of screening tests and treatments available for cervical cancer screening and prevention, the costs associated with these options and with their alternatives, and the differences in resources and settings in which these tests are applied worldwide, cost-effectiveness analyses evaluation can be very useful to help determine best practices.
ISSN:	0009-9201 1532-5520
DOI:	10.1097/GRF.0b013e3182823797